Another ROC analysis showed that SRXN1 and KRT6A could clearly distinguish patients with NSCLC from healthy individuals (AUC = 74.8% in TCGA for SRXN1 and 76.9% in TCGA for KRT6A, Figures 3D, E). Here, SRXN1 is linked to non-small cell lung carcinoma.